submit url • add directory • Nursing jobs ♦ Occupational Nurse jobs
Today's News:
Advances in Psychiatric Treatment current issue
Stigma and exclusion [From the Trainee Editor]
Conlan, L. Tue, 03 Jan 2012 00:05:53 -0800
Gender dysphoria: recognition and assessment [Articles]
Eden, K., Wylie, K., Watson, E. Tue, 03 Jan 2012 00:05:54 -0800
The role of the mental health professional, and of the psychiatrist in particular, is evolving and changing. As the recognition of transsexualism and gender identity disorder expands across the transgender spectrum, it has been recommended that gender dysphoria should replace existing diagnostic terminology. Patient-focused care is evolving and this article considers the limitations of current healthcare settings and how the mental health professional can support patients undergoing the real-life experience. Differentiation from other mental health conditions that may present as gender dysphoria is outlined, as well as specific clinical situations.
Gender dysphoria: treatment and outcomes [Articles]
Wylie, K., Eden, K., Watson, E. Tue, 03 Jan 2012 00:05:54 -0800
Once a formal diagnosis of gender dysphoria is established and comorbid disorders addressed, it is the role of the gender specialist to facilitate treatment according to agreed goals. This article reviews the treatment of gender dysphoria, including psychotherapy, and how eligibility and readiness for surgery are assessed. It considers issues facing transgender individuals detained in prison or psychiatric hospital, the factors that affect patients’ satisfaction with gender reassignment surgery and how the specialist can ensure a satisfactory outcome.
Locum Tenens Psychiatry Adult Jobs
Psychiatry Adult jobs
Thu, 09 Feb 2012 00:57:46 -0500
All Psychiatry Adult jobs for Thu Feb 9 2012
Psychiatry Adult jobs in "Southeastern/South Shore of Boston" - MA
Fri, 03 Feb 2012 13:27:44 -0500
We have an outstanding on-going LOCUMS opportunity for an Adult Psychiatrist in the Southeastern/South Shore of Boston, MA. Board Certified is preferred but Board Eligible will
Psychiatry Adult jobs in "Greater Lehigh Valley" - PA
Fri, 03 Feb 2012 13:27:44 -0500
Our very prestigious client in the Greater Lehigh Valley area of PA is in need of a LOCUMS BC/BE Adult Psychiatrist. Board Certified is preferred but Board Eligible will
Archives of General Psychiatry current issue
Suicidal Thoughts and Behavior With Antidepressant Treatment: Reanalysis of the Randomized Placebo-Controlled Studies of Fluoxetine and Venlafaxine [Meta-analysis]
Gibbons, R. D., Brown, C. H., Hur, K., Davis, J. M., Mann, J. J. Mon, 06 Feb 2012 12:41:16 -0800
Context The US Food and Drug Administration issued a black box warning for antidepressants and suicidal thoughts and behavior in children and young adults. Objective To determine the short-term safety of antidepressants by standard assessments of suicidal thoughts and behavior in youth, adult, and geriatric populations and the mediating effect of changes in depressive symptoms. Data Sources All intent-to-treat person-level longitudinal data of major depressive disorder from 12 adult, 4 geriatric, and 4 youth randomized controlled trials of fluoxetine hydrochloride and 21 adult trials of venlafaxine hydrochloride. Study Selection All sponsor-conducted randomized controlled trials of fluoxetine and venlafaxine. Data Extraction The suicide items from the Children's Depression Rating Scale–Revised and the Hamilton Depression Rating Scale as well as adverse event reports of suicide attempts and suicide during active treatment were analyzed in 9185 patients (fluoxetine: 2635 adults, 960 geriatric patients, 708 youths; venlafaxine: 2421 adults with immediate-release venlafaxine and 2461 adults with extended-release venlafaxine) for a total of 53 260 person-week observations. Data Synthesis Suicidal thoughts and behavior decreased over time for adult and geriatric patients randomized to fluoxetine or venlafaxine compared with placebo, but no differences were found for youths. In adults, reduction in suicide ideation and attempts occurred through a reduction in depressive symptoms. In all age groups, severity of depression improved with medication and was significantly related to suicide ideation or behavior. Conclusions Fluoxetine and venlafaxine decreased suicidal thoughts and behavior for adult and geriatric patients. This protective effect is mediated by decreases in depressive symptoms with treatment. For youths, no significant effects of treatment on suicidal thoughts and behavior were found, although depression responded to treatment. No evidence of increased suicide risk was observed in youths receiving active medication. To our knowledge, this is the first research synthesis of suicidal thoughts and behavior in depressed patients treated with antidepressants that examined the mediating role of depressive symptoms using complete longitudinal person-level data from a large set of published and unpublished studies.
Influence of Patient Race and Ethnicity on Clinical Assessment in Patients With Affective Disorders [Original Article]
Gara, M. A., Vega, W. A., Arndt, S., Escamilla, M., Fleck, D. E., Lawson, W. B., Lesser, I., Neighbors, H. W., Wilson, D. R., Strakowski, S. M. Mon, 06 Feb 2012 12:41:04 -0800
Context Rates of clinical diagnoses of schizophrenia in African American individuals appear to be elevated compared with other ethnic groups in the United States, contradicting population rates derived from epidemiologic surveys. Objective To determine whether African American individuals would continue to exhibit significantly higher rates of clinical diagnoses of schizophrenia, even after controlling for age, sex, income, site, and education, as well as the presence or absence of serious affective disorder, as determined by experts blinded to race and ethnicity. A secondary objective was to determine if a similar pattern occurred in Latino subjects. Design Ethnicity-blinded and -unblinded diagnostic assessments were obtained in 241 African American individuals (mean [SD] age, 34.3 [8.1] years; 57% women), 220 non-Latino white individuals (mean [SD] age, 32.7 [8.5] years; 53% women), and 149 Latino individuals (mean [SD] age, 33.5 [8.0] years; 58% women) at 6 US sites. Logistic regression models were used to determine whether elevated rates of schizophrenia in African American individuals would persist after controlling for various confounding variables including blinded expert consensus diagnoses of serious affective illness. Settings Six academic medical centers across the United States. Participants Six hundred ten psychiatric inpatients and outpatients. Main Outcome Measure Relative odds of unblinded clinical diagnoses of schizophrenia in African American compared with white individuals. Results A significant ethnicity/race effect (22 = 10.4, P = .01) was obtained when schizophrenia was narrowly defined, controlling for all other predictors. The odds ratio comparing African American with non-Latino white individuals was significant (odds ratio = 2.7; 95% CI, 1.5-5.1). Similar differences between African American and white individuals occurred when schizophrenia was more broadly defined (odds ratio = 2.5; 95% CI, 1.4-4.5). African American individuals did not differ significantly from white individuals in overall severity of manic and depressive symptoms but did evidence more severe psychosis. Conclusions African American individuals exhibited significantly higher rates of clinical diagnoses of schizophrenia than non-Latino white subjects, even after controlling for covariates such as serious affective disorder.
Impact of Smoking on Cognitive Decline in Early Old Age: The Whitehall II Cohort Study [Original Article]
Sabia, S., Elbaz, A., Dugravot, A., Head, J., Shipley, M., Hagger-Johnson, G., Kivimaki, M., Singh-Manoux, A. Mon, 06 Feb 2012 12:40:53 -0800
Context Smoking is a possible risk factor for dementia, although its impact may have been underestimated in elderly populations because of the shorter life span of smokers. Objective To examine the association between smoking history and cognitive decline in the transition from midlife to old age. Design Cohort study. Setting The Whitehall II study. The first cognitive assessment was in 1997 to 1999, repeated over 2002 to 2004 and 2007 to 2009. Participants Data are from 5099 men and 2137 women in the Whitehall II study, mean age 56 years (range, 44-69 years) at the first cognitive assessment. Main Outcome Measures The cognitive test battery was composed of tests of memory, vocabulary, executive function (composed of 1 reasoning and 2 fluency tests), and a global cognitive score summarizing performance across all 5 tests. Smoking status was assessed over the entire study period. Linear mixed models were used to assess the association between smoking history and 10-year cognitive decline, expressed as z scores. Results In men, 10-year cognitive decline in all tests except vocabulary among never smokers ranged from a quarter to a third of the baseline standard deviation. Faster cognitive decline was observed among current smokers compared with never smokers in men (mean difference in 10-year decline in global cognition = –0.09 [95% CI, –0.15 to –0.03] and executive function = –0.11 [95% CI, –0.17 to –0.05]). Recent ex-smokers had greater decline in executive function (–0.08 [95% CI, –0.14 to –0.02]), while the decline in long-term ex-smokers was similar to that among never smokers. In analyses that additionally took dropout and death into account, these differences were 1.2 to 1.5 times larger. In women, cognitive decline did not vary as a function of smoking status. Conclusions Compared with never smokers, middle-aged male smokers experienced faster cognitive decline in global cognition and executive function. In ex-smokers with at least a 10-year cessation, there were no adverse effects on cognitive decline.
Permanent Psychiatry Jobs
Psychiatry jobs
Thu, 09 Feb 2012 00:59:17 -0500
All Psychiatry jobs for Thu Feb 9 2012
Psychiatry jobs in "Located 1 hour 45 Minutes Northwest of Atlanta" - GA
Fri, 03 Feb 2012 13:27:44 -0500
Psychiatry Opportunity Located 1 hour 45 Minutes Northwest of Atlanta Hospital is seeking someone that is hardworking and interested in patient care needs Both In and Out Patient work is required Seeing
Psychiatry jobs in "Los Angeles" - CA
Thu, 02 Feb 2012 13:27:44 -0500
Psychiatrist wanted for opportunity located on the Blue Pacific shore. Live the California lifestyle of beaches, mountains, and theme parks. Ventura County is a short commute to Los Angeles, live
Subscribe to Psychiatry RSS feed 
Stigma and exclusion [From the Trainee Editor]
Conlan, L. Tue, 03 Jan 2012 00:05:53 -0800
Gender dysphoria: recognition and assessment [Articles]
Eden, K., Wylie, K., Watson, E. Tue, 03 Jan 2012 00:05:54 -0800
The role of the mental health professional, and of the psychiatrist in particular, is evolving and changing. As the recognition of transsexualism and gender identity disorder expands across the transgender spectrum, it has been recommended that gender dysphoria should replace existing diagnostic terminology. Patient-focused care is evolving and this article considers the limitations of current healthcare settings and how the mental health professional can support patients undergoing the real-life experience. Differentiation from other mental health conditions that may present as gender dysphoria is outlined, as well as specific clinical situations.
Gender dysphoria: treatment and outcomes [Articles]
Wylie, K., Eden, K., Watson, E. Tue, 03 Jan 2012 00:05:54 -0800
Once a formal diagnosis of gender dysphoria is established and comorbid disorders addressed, it is the role of the gender specialist to facilitate treatment according to agreed goals. This article reviews the treatment of gender dysphoria, including psychotherapy, and how eligibility and readiness for surgery are assessed. It considers issues facing transgender individuals detained in prison or psychiatric hospital, the factors that affect patients’ satisfaction with gender reassignment surgery and how the specialist can ensure a satisfactory outcome.
Locum Tenens Psychiatry Adult Jobs
Psychiatry Adult jobs
Thu, 09 Feb 2012 00:57:46 -0500
All Psychiatry Adult jobs for Thu Feb 9 2012
Psychiatry Adult jobs in "Southeastern/South Shore of Boston" - MA
Fri, 03 Feb 2012 13:27:44 -0500
We have an outstanding on-going LOCUMS opportunity for an Adult Psychiatrist in the Southeastern/South Shore of Boston, MA. Board Certified is preferred but Board Eligible will
Psychiatry Adult jobs in "Greater Lehigh Valley" - PA
Fri, 03 Feb 2012 13:27:44 -0500
Our very prestigious client in the Greater Lehigh Valley area of PA is in need of a LOCUMS BC/BE Adult Psychiatrist. Board Certified is preferred but Board Eligible will
Archives of General Psychiatry current issue
Suicidal Thoughts and Behavior With Antidepressant Treatment: Reanalysis of the Randomized Placebo-Controlled Studies of Fluoxetine and Venlafaxine [Meta-analysis]
Gibbons, R. D., Brown, C. H., Hur, K., Davis, J. M., Mann, J. J. Mon, 06 Feb 2012 12:41:16 -0800
Context The US Food and Drug Administration issued a black box warning for antidepressants and suicidal thoughts and behavior in children and young adults. Objective To determine the short-term safety of antidepressants by standard assessments of suicidal thoughts and behavior in youth, adult, and geriatric populations and the mediating effect of changes in depressive symptoms. Data Sources All intent-to-treat person-level longitudinal data of major depressive disorder from 12 adult, 4 geriatric, and 4 youth randomized controlled trials of fluoxetine hydrochloride and 21 adult trials of venlafaxine hydrochloride. Study Selection All sponsor-conducted randomized controlled trials of fluoxetine and venlafaxine. Data Extraction The suicide items from the Children's Depression Rating Scale–Revised and the Hamilton Depression Rating Scale as well as adverse event reports of suicide attempts and suicide during active treatment were analyzed in 9185 patients (fluoxetine: 2635 adults, 960 geriatric patients, 708 youths; venlafaxine: 2421 adults with immediate-release venlafaxine and 2461 adults with extended-release venlafaxine) for a total of 53 260 person-week observations. Data Synthesis Suicidal thoughts and behavior decreased over time for adult and geriatric patients randomized to fluoxetine or venlafaxine compared with placebo, but no differences were found for youths. In adults, reduction in suicide ideation and attempts occurred through a reduction in depressive symptoms. In all age groups, severity of depression improved with medication and was significantly related to suicide ideation or behavior. Conclusions Fluoxetine and venlafaxine decreased suicidal thoughts and behavior for adult and geriatric patients. This protective effect is mediated by decreases in depressive symptoms with treatment. For youths, no significant effects of treatment on suicidal thoughts and behavior were found, although depression responded to treatment. No evidence of increased suicide risk was observed in youths receiving active medication. To our knowledge, this is the first research synthesis of suicidal thoughts and behavior in depressed patients treated with antidepressants that examined the mediating role of depressive symptoms using complete longitudinal person-level data from a large set of published and unpublished studies.
Influence of Patient Race and Ethnicity on Clinical Assessment in Patients With Affective Disorders [Original Article]
Gara, M. A., Vega, W. A., Arndt, S., Escamilla, M., Fleck, D. E., Lawson, W. B., Lesser, I., Neighbors, H. W., Wilson, D. R., Strakowski, S. M. Mon, 06 Feb 2012 12:41:04 -0800
Context Rates of clinical diagnoses of schizophrenia in African American individuals appear to be elevated compared with other ethnic groups in the United States, contradicting population rates derived from epidemiologic surveys. Objective To determine whether African American individuals would continue to exhibit significantly higher rates of clinical diagnoses of schizophrenia, even after controlling for age, sex, income, site, and education, as well as the presence or absence of serious affective disorder, as determined by experts blinded to race and ethnicity. A secondary objective was to determine if a similar pattern occurred in Latino subjects. Design Ethnicity-blinded and -unblinded diagnostic assessments were obtained in 241 African American individuals (mean [SD] age, 34.3 [8.1] years; 57% women), 220 non-Latino white individuals (mean [SD] age, 32.7 [8.5] years; 53% women), and 149 Latino individuals (mean [SD] age, 33.5 [8.0] years; 58% women) at 6 US sites. Logistic regression models were used to determine whether elevated rates of schizophrenia in African American individuals would persist after controlling for various confounding variables including blinded expert consensus diagnoses of serious affective illness. Settings Six academic medical centers across the United States. Participants Six hundred ten psychiatric inpatients and outpatients. Main Outcome Measure Relative odds of unblinded clinical diagnoses of schizophrenia in African American compared with white individuals. Results A significant ethnicity/race effect (22 = 10.4, P = .01) was obtained when schizophrenia was narrowly defined, controlling for all other predictors. The odds ratio comparing African American with non-Latino white individuals was significant (odds ratio = 2.7; 95% CI, 1.5-5.1). Similar differences between African American and white individuals occurred when schizophrenia was more broadly defined (odds ratio = 2.5; 95% CI, 1.4-4.5). African American individuals did not differ significantly from white individuals in overall severity of manic and depressive symptoms but did evidence more severe psychosis. Conclusions African American individuals exhibited significantly higher rates of clinical diagnoses of schizophrenia than non-Latino white subjects, even after controlling for covariates such as serious affective disorder.
Impact of Smoking on Cognitive Decline in Early Old Age: The Whitehall II Cohort Study [Original Article]
Sabia, S., Elbaz, A., Dugravot, A., Head, J., Shipley, M., Hagger-Johnson, G., Kivimaki, M., Singh-Manoux, A. Mon, 06 Feb 2012 12:40:53 -0800
Context Smoking is a possible risk factor for dementia, although its impact may have been underestimated in elderly populations because of the shorter life span of smokers. Objective To examine the association between smoking history and cognitive decline in the transition from midlife to old age. Design Cohort study. Setting The Whitehall II study. The first cognitive assessment was in 1997 to 1999, repeated over 2002 to 2004 and 2007 to 2009. Participants Data are from 5099 men and 2137 women in the Whitehall II study, mean age 56 years (range, 44-69 years) at the first cognitive assessment. Main Outcome Measures The cognitive test battery was composed of tests of memory, vocabulary, executive function (composed of 1 reasoning and 2 fluency tests), and a global cognitive score summarizing performance across all 5 tests. Smoking status was assessed over the entire study period. Linear mixed models were used to assess the association between smoking history and 10-year cognitive decline, expressed as z scores. Results In men, 10-year cognitive decline in all tests except vocabulary among never smokers ranged from a quarter to a third of the baseline standard deviation. Faster cognitive decline was observed among current smokers compared with never smokers in men (mean difference in 10-year decline in global cognition = –0.09 [95% CI, –0.15 to –0.03] and executive function = –0.11 [95% CI, –0.17 to –0.05]). Recent ex-smokers had greater decline in executive function (–0.08 [95% CI, –0.14 to –0.02]), while the decline in long-term ex-smokers was similar to that among never smokers. In analyses that additionally took dropout and death into account, these differences were 1.2 to 1.5 times larger. In women, cognitive decline did not vary as a function of smoking status. Conclusions Compared with never smokers, middle-aged male smokers experienced faster cognitive decline in global cognition and executive function. In ex-smokers with at least a 10-year cessation, there were no adverse effects on cognitive decline.
Permanent Psychiatry Jobs
Psychiatry jobs
Thu, 09 Feb 2012 00:59:17 -0500
All Psychiatry jobs for Thu Feb 9 2012
Psychiatry jobs in "Located 1 hour 45 Minutes Northwest of Atlanta" - GA
Fri, 03 Feb 2012 13:27:44 -0500
Psychiatry Opportunity Located 1 hour 45 Minutes Northwest of Atlanta Hospital is seeking someone that is hardworking and interested in patient care needs Both In and Out Patient work is required Seeing
Psychiatry jobs in "Los Angeles" - CA
Thu, 02 Feb 2012 13:27:44 -0500
Psychiatrist wanted for opportunity located on the Blue Pacific shore. Live the California lifestyle of beaches, mountains, and theme parks. Ventura County is a short commute to Los Angeles, live
Sites:
Psychiatric jobs: Listings of employment opportunities for psychiatric physicians in North America. Automatic email updates of newest job postings.At Health Medicine Cabinet: Information about medications used to treat mental disorders, descriptions of mental health disorders.
Consultation and Liaison Manual: The Department of Human Services, Victoria, Australia, Victorian Government Health Information Website. Health.vic.gov.au is a gateway to information relating to the provision of health services in Victoria. The pages in this Website are developed and managed by the Department of Human Se...
Emergency Psychiatry Service Handbook: Virtual Hospital was a digital library of health information in pediatrics, paediatrics, and radiology for pediatric education and radiology education
Family Practice Notebook: Psychiatry: Reviews Anxiety, Behavior, Bipolar, Chemical Dependency, Depression, Eating, Examination, Hypnosis, Mood, Procedure, Psychosis, Sleep Disorders and Somatization. Related chapters from other specialties include Dermatology, Ophthalmology, Geriatric, Laboratory, Neurology, Obstetrics, Pediatrics, ...
General Practice Notebook - Psychiatry: Coverage of this medical speciality.
Mark Levy MD: Extensive Forensic Psychiatry recource, what's new in Forensic Psychiatry, continually updated.
National Association of Psychiatric Health Systems: NAPHS offers advocacy, clinical, financial, and administrative resources for psychiatric patients and providers while working to coordinate a full spectrum of psychiatric treatment services.
Netherlands PTSD Treatment Center: Home page of Foundation Centrum '45 for clinical, out-patient and day-care therapy for victims of war and political violence and their families and education and research on psychotraumatology
Psychejam: Psychiatric revision site for trainees in all disciplines. Predominently for mental health professionals.
Psychiatry 24x7 for the UK: Contains resources for, with specific focus, on schizophrenia, depression, bipolar disorder and anxiety. Provides live psychiatry news links, education, ecards, quizzes and polls.
Psychiatry Direct: Mental Health, information and guidance, psychiatric advice, self-help, access to Consultant Psychiatrist in London and south-east UK
Psychiatry Information for the Public: Includes information, diagnosis, definitions, mental health criteria, screening tests, medication, psychiatric disorders, treatment, self-help advice presented in easy to understand, popularized language in this NYU Department of Psychiatry web site.
Psychiatry24x7: Psychiatry24x7.com provides in-depth information on mental disorders including schizophrenia, bipolar disorder, ADHD and child psychiatry, depression, anxiety and substance abuse for patients, caregivers and healthcare professionals.
PsychLinx .com: Psychiatry news, newsletters, journal articles. PsychLinx aggregates current medical research.
Psychoneuroendocrinology Research Group: Describes current research studies for mood and dual diagnosis disorders at Southwestern Medical in Dallas, Texas.
St. John of God Hospital Stillorgan: Located in Stillorgan, Dublin. Assessment programs for numerous psychiatric disorders.
The Dark Side of Psychiatry: The dark side of Psychiatry - Illogicality, illusions and failure of biopsychiatry. The Politics of Madness / ECT, ...
The Merck Manual Section 15 on Mental Health Disorders: The full text of section 15 of the Merck Manual. Covers all mental health disorders in depth.
The Ninth Street Center: dedicated to the ground-breaking work of Paul Rosenfels in developing a science of human nature.
This directory is based on the Open Directory and may have been modified